Erste Ergebnisse zur multizentrischen, randomisierten, kontrollierten Brustkrebs-Diagnostikstudie ToSyMa
Senologie - Zeitschrift für Mammadiagnostik und -therapie 2022; 18(02): 125-126; DOI: 10.1055/a-1826-6228
Digital breast tomosynthesis plus synthesized mammography versus digital screening mammography for the detection of invasive breast cancer (TOSYMA): a multicentre, open-label, randomized, controlled, superiority trial
Lancet Oncol. 2022 May;23(5):601-611. doi: 10.1016/S1470-2045(22)00194-2. Epub 2022 Apr 12.
Das Mammografie-Screening: Sollte es abgeschafft werden?
Geburtshilfe Frauenheilkd 2021; 81(09): 1011-1013 DOI: 10.1055/a-1372-7531
Simultaneous FAPI PET/MRI Targeting the Fibroblast-Activation Protein for Breast Cancer
Radiology 2021; 000:1–9 https://doi.org/10.1148/radiol.2021204677
PET of Fibroblast-Activation Protein for Breast Cancer Diagnosis and Staging
Radiology 2021; 00:1–2 https://doi.org/10.1148/radiol.2021212098
Magnetic resonance imaging before breast cancer surgery: results of an observational multicenter international prospective analysis (MIPA)
European Radiology, 13 October 2021; doi: https://doi.org/10.1007/s00330-021-08240-x